⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

July 26, 2019Arthritis Research & TherapyOpen Access

Disease interception with interleukin-17 inhibition in high-risk psoriasis patients with subclinical joint inflammation—data from the prospective IVEPSA study

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Trial registry name PSARTROS; trial registry number: NCT02483234; June 26, 2015.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kampylafka et al. (2019) studied this question.

synapsesocial.com/papers/69d6943c7244fdb465029d30 https://doi.org/10.1186/s13075-019-1957-0

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1<i>In Vivo</i>Assessment of Trabecular Bone Microarchitecture by High-Resolution Peripheral Quantitative Computed TomographyCross-Sectional Study · 2005 · 1,197 citations
2Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic ArthritisRCT · 2015 · 752 citations
3Biomechanical properties of bone are impaired in patients with ACPA-positive rheumatoid arthritis and associated with the occurrence of fracturesRetrospective Study · 2018 · 47 citations
4Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: A population‐based studyCohort Study · 2009 · 608 citations
5The Development of Psoriatic Arthritis in Patients With Psoriasis Is Preceded by a Period of Nonspecific Musculoskeletal Symptoms: A Prospective Cohort StudyCohort Study · 2016 · 141 citations